abstract |
New imidazolylalkyl-guanidine derivatives are described, which by virtue of their agonistic action on histamine-H2 receptors and in part also due to their additional H1antagonistic receptor activdty can be used in the treatment of cardiac diseases, certain forms of hypertension and diseases of arterial occlusion, These imidazolylalkyl-guanidine derivatives correspond to the general formula I: (I) <IMG> |